NDC 73536-500

BESREMi

Ropeginterferon Alfa-2b

BESREMi is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Pharmaessentia Usa. The primary component is Ropeginterferon Alfa-2b.

• Product ID: 73536-500_89b4913a-7822-4605-9765-2fdd0121107b
• NDC: 73536-500
• Product Type: Human Prescription Drug
• Proprietary Name: BESREMi
• Generic Name: Ropeginterferon Alfa-2b
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-11-12
• Marketing Category: BLA /
• Application Number: BLA761166
• Labeler Name: PharmaEssentia USA
• Substance Name: ROPEGINTERFERON ALFA-2B
• Active Ingredient Strength: 500 ug/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 73536-500-01

1 SYRINGE, GLASS in 1 CARTON (73536-500-01) > 1 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 2021-11-12
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details